vs

Side-by-side financial comparison of ClearSign Technologies Corp (CLIR) and FOCUS UNIVERSAL INC. (FCUV). Click either name above to swap in a different company.

ClearSign Technologies Corp is the larger business by last-quarter revenue ($3.7M vs $749, roughly 4901.2× FOCUS UNIVERSAL INC.). On growth, ClearSign Technologies Corp posted the faster year-over-year revenue change (522.2% vs -99.4%). Over the past eight quarters, ClearSign Technologies Corp's revenue compounded faster (82.5% CAGR vs -93.5%).

ClearSign Technologies Corporation (ClearSign) is a United States-based company that develops emission-control technology.

Universal Health Services, Inc. (UHS) is an American Fortune 500 company that provides hospital and healthcare services, based in King of Prussia, Pennsylvania. In 2024, UHS reported total revenues of $15.8 billion.

CLIR vs FCUV — Head-to-Head

Bigger by revenue
CLIR
CLIR
4901.2× larger
CLIR
$3.7M
$749
FCUV
Growing faster (revenue YoY)
CLIR
CLIR
+621.6% gap
CLIR
522.2%
-99.4%
FCUV
Faster 2-yr revenue CAGR
CLIR
CLIR
Annualised
CLIR
82.5%
-93.5%
FCUV

Income Statement — Q4 2025 vs Q4 2025

Metric
CLIR
CLIR
FCUV
FCUV
Revenue
$3.7M
$749
Net Profit
$-311.0K
Gross Margin
21.9%
-6912.1%
Operating Margin
-22.5%
-119973.6%
Net Margin
-8.5%
Revenue YoY
522.2%
-99.4%
Net Profit YoY
73.3%
EPS (diluted)
$-0.06

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLIR
CLIR
FCUV
FCUV
Q4 25
$3.7M
$749
Q3 25
$1.0M
$28.7K
Q2 25
$133.0K
$35.3K
Q1 25
$401.0K
$190.3K
Q4 24
$590.0K
$133.2K
Q3 24
$1.9M
$74.2K
Q2 24
$45.0K
$11.2K
Q1 24
$1.1M
$179.5K
Net Profit
CLIR
CLIR
FCUV
FCUV
Q4 25
$-311.0K
Q3 25
$-1.4M
$-1.2M
Q2 25
$-1.7M
$-1.5M
Q1 25
$-2.1M
$-1.3M
Q4 24
$-1.2M
Q3 24
$-1.2M
$1.4M
Q2 24
$-1.9M
$-1.4M
Q1 24
$-1.1M
$-1.3M
Gross Margin
CLIR
CLIR
FCUV
FCUV
Q4 25
21.9%
-6912.1%
Q3 25
35.8%
-5.6%
Q2 25
41.4%
-35.1%
Q1 25
48.9%
16.1%
Q4 24
14.9%
-95.4%
Q3 24
29.6%
42.7%
Q2 24
93.3%
Q1 24
39.7%
50.3%
Operating Margin
CLIR
CLIR
FCUV
FCUV
Q4 25
-22.5%
-119973.6%
Q3 25
-170.1%
-4114.4%
Q2 25
-1382.0%
-4366.7%
Q1 25
-562.8%
-668.3%
Q4 24
-282.4%
-1507.4%
Q3 24
-77.1%
-2353.8%
Q2 24
-4748.9%
-10965.3%
Q1 24
-113.6%
-676.3%
Net Margin
CLIR
CLIR
FCUV
FCUV
Q4 25
-8.5%
Q3 25
-138.9%
-4065.6%
Q2 25
-1263.2%
-4261.7%
Q1 25
-517.7%
-657.7%
Q4 24
-197.3%
Q3 24
-62.1%
1942.9%
Q2 24
-4160.0%
-12151.6%
Q1 24
-100.5%
-732.9%
EPS (diluted)
CLIR
CLIR
FCUV
FCUV
Q4 25
$-0.06
Q3 25
$-0.26
Q2 25
$-0.30
Q1 25
$-0.37
$-0.17
Q4 24
$-0.18
$-4.57
Q3 24
$-0.20
$0.02
Q2 24
$-0.40
$-0.02
Q1 24
$-0.30
$-0.20

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLIR
CLIR
FCUV
FCUV
Cash + ST InvestmentsLiquidity on hand
$9.2M
$8.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$9.5M
$2.6M
Total Assets
$12.2M
$8.9M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLIR
CLIR
FCUV
FCUV
Q4 25
$9.2M
$8.0M
Q3 25
$10.5M
$454.4K
Q2 25
$12.3M
$1.2M
Q1 25
$12.9M
$2.2M
Q4 24
$14.0M
$3.6M
Q3 24
$14.5M
$5.4M
Q2 24
$16.0M
$40.6K
Q1 24
$4.6M
$114.1K
Stockholders' Equity
CLIR
CLIR
FCUV
FCUV
Q4 25
$9.5M
$2.6M
Q3 25
$9.1M
$174.8K
Q2 25
$10.4M
$845.6K
Q1 25
$12.0M
$1.9M
Q4 24
$13.8M
$3.2M
Q3 24
$14.8M
$5.4M
Q2 24
$15.9M
$1.2M
Q1 24
$4.5M
$2.4M
Total Assets
CLIR
CLIR
FCUV
FCUV
Q4 25
$12.2M
$8.9M
Q3 25
$12.7M
$880.4K
Q2 25
$14.2M
$1.7M
Q1 25
$14.5M
$2.7M
Q4 24
$16.3M
$4.1M
Q3 24
$17.1M
$6.2M
Q2 24
$17.8M
$4.9M
Q1 24
$6.6M
$5.0M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLIR
CLIR
FCUV
FCUV
Operating Cash FlowLast quarter
$-1.3M
$-1.4M
Free Cash FlowOCF − Capex
$-1.4M
FCF MarginFCF / Revenue
-186175.6%
Capex IntensityCapex / Revenue
0.0%
105.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-5.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLIR
CLIR
FCUV
FCUV
Q4 25
$-1.3M
$-1.4M
Q3 25
$-1.8M
$-1.1M
Q2 25
$-511.0K
$-1.4M
Q1 25
$-1.1M
$-1.2M
Q4 24
$-415.0K
$-997.9K
Q3 24
$-1.4M
$-1.9M
Q2 24
$-1.5M
$-829.9K
Q1 24
$-1.0M
$-892.1K
Free Cash Flow
CLIR
CLIR
FCUV
FCUV
Q4 25
$-1.4M
Q3 25
$-1.1M
Q2 25
$-1.4M
Q1 25
$-1.1M
$-1.2M
Q4 24
$-1.0M
Q3 24
$-1.9M
Q2 24
$-834.6K
Q1 24
$-897.1K
FCF Margin
CLIR
CLIR
FCUV
FCUV
Q4 25
-186175.6%
Q3 25
-3705.4%
Q2 25
-4047.4%
Q1 25
-278.1%
-653.6%
Q4 24
-753.3%
Q3 24
-2614.6%
Q2 24
-7428.8%
Q1 24
-499.8%
Capex Intensity
CLIR
CLIR
FCUV
FCUV
Q4 25
0.0%
105.2%
Q3 25
0.0%
7.8%
Q2 25
0.0%
4.8%
Q1 25
1.0%
12.3%
Q4 24
4.1%
Q3 24
0.0%
4.7%
Q2 24
41.8%
Q1 24
2.8%
Cash Conversion
CLIR
CLIR
FCUV
FCUV
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
-1.34×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons